PHARMACOGENETIC PERSPECTIVES GAINED FROM TWIN AND FAMILY STUDIES

被引:58
作者
VESELL, ES
机构
关键词
D O I
10.1016/0163-7258(89)90130-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:535 / 552
页数:18
相关论文
共 57 条
[1]   STEADY-STATE PLASMA LEVELS OF NORTRIPTYLINE INTWINS - INFLUENCE OF GENETIC FACTORS AND DRUG THERAPY [J].
ALEXANDERSON, B ;
EVANS, DAP ;
SJOQVIST, F .
BMJ-BRITISH MEDICAL JOURNAL, 1969, 4 (5686) :764-+
[2]  
ANDREASEN P B, 1973, Acta Medica Scandinavica, V193, P561
[3]   GENETIC CONROL OF NORTIPTYLINE KINETICS IN MAN - STUDY OF RELATIVES OF PROPOSITI WITH HIGH PLASMA CONCENTRATIONS [J].
ASBERG, M ;
EVANS, DAP ;
SJOQVIST, F .
JOURNAL OF MEDICAL GENETICS, 1971, 8 (02) :129-&
[4]   HUMAN DRUG-METABOLISM INVITRO [J].
BEAUNE, PH ;
GUENGERICH, FP .
PHARMACOLOGY & THERAPEUTICS, 1988, 37 (02) :193-211
[5]   FAMILY STUDY OF ANTIPYRINE CLEARANCE [J].
BLAIN, PG ;
MUCKLOW, JC ;
WOOD, P ;
ROBERTS, DF ;
RAWLINS, MD .
BRITISH MEDICAL JOURNAL, 1982, 284 (6310) :150-152
[6]  
CASCORBI HF, 1971, CLIN PHARMACOL THER, V12, P50
[7]  
Cohen J., 1983, APPL MULTIPLE REGRES, V2
[8]  
COHEN SN, 1972, PEDIATR CLIN N AM, V19, P21
[10]  
ELLIS EF, 1976, PEDIATRICS, V58, P542